Burzynski Research Institute, Inc.
|
-1.33 Million USD
|
-36.01%
|
Arch Therapeutics, Inc.
|
-5.04 Million USD
|
63.994%
|
Evofem Biosciences, Inc.
|
-17.84 Million USD
|
89.823%
|
Nascent Biotech, Inc.
|
-2.22 Million USD
|
18.546%
|
Rebus Holdings, Inc.
|
-664 Thousand USD
|
-173.542%
|
Santhera Pharmaceuticals Holding AG
|
81.85 Million USD
|
102.219%
|
Qrons Inc.
|
-643.67 Thousand USD
|
-182.179%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-389.57 Thousand USD
|
-366.237%
|
Northwest Biotherapeutics, Inc.
|
-55.5 Million USD
|
96.728%
|
ProtoKinetix, Incorporated
|
-415.47 Thousand USD
|
-337.163%
|
Skye Bioscience, Inc.
|
-13.67 Million USD
|
86.715%
|
Eiger BioPharmaceuticals, Inc.
|
-71.78 Million USD
|
97.47%
|
Nanobac Pharmaceuticals, Incorporated
|
4.91 Million USD
|
136.956%
|
Institute of Biomedical Research Corp.
|
-261.72 Thousand USD
|
-593.978%
|
SQZ Biotechnologies Company
|
-75.82 Million USD
|
97.605%
|
Intellipharmaceutics International Inc.
|
-2.85 Million USD
|
36.281%
|
Propanc Biopharma, Inc.
|
-1.53 Million USD
|
-18.246%
|
Mesoblast Limited
|
-84.14 Million USD
|
97.841%
|
Marizyme, Inc.
|
-34.08 Million USD
|
94.671%
|
Genus plc
|
6.4 Million USD
|
128.38%
|
VioQuest Pharmaceuticals, Inc.
|
9.74 Million USD
|
118.643%
|
Pharming Group N.V.
|
-4.87 Million USD
|
62.777%
|
Therapeutic Solutions International, Inc.
|
-1.98 Million USD
|
8.566%
|
CNBX Pharmaceuticals Inc.
|
-931.38 Thousand USD
|
-95.014%
|
Nymox Pharmaceutical Corporation
|
-8.35 Million USD
|
78.248%
|
ContraFect Corporation
|
-56.88 Million USD
|
96.807%
|
PsyBio Therapeutics Corp.
|
-4.55 Million USD
|
60.122%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-1.4 Million USD
|
-29.553%
|
IMV Inc.
|
-38.67 Million USD
|
95.303%
|
AXIM Biotechnologies, Inc.
|
-2.75 Million USD
|
33.972%
|
MultiCell Technologies, Inc.
|
-722.81 USD
|
-251185.953%
|
ONE Bio Corp.
|
13.68 Million USD
|
113.276%
|
Accustem Sciences Inc.
|
-3.74 Million USD
|
51.519%
|
RVL Pharmaceuticals plc
|
-58.99 Million USD
|
96.921%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-483.06 Thousand USD
|
-276.001%
|
Q BioMed Inc.
|
-3.44 Million USD
|
47.286%
|
Emmaus Life Sciences, Inc.
|
3.54 Million USD
|
151.308%
|
Mosaic ImmunoEngineering Inc.
|
-2.62 Million USD
|
30.873%
|
Biomind Labs Inc.
|
-1 Million USD
|
-79.904%
|
American Oriental Bioengineering, Inc.
|
-54.97 Million USD
|
96.696%
|
Provectus Biopharmaceuticals, Inc.
|
-2.9 Million USD
|
37.395%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-6.64 Million USD
|
72.679%
|
GlobeStar Therapeutics Corporation
|
-1.86 Million USD
|
2.577%
|
THC Farmaceuticals, Inc.
|
-29.95 Thousand USD
|
-5964.103%
|
Acro Biomedical Co., Ltd.
|
-15.86 Million USD
|
88.555%
|
Curative Biotechnology, Inc.
|
-1.93 Million USD
|
6.017%
|
GB Sciences, Inc.
|
-1.42 Million USD
|
-27.864%
|
Alpha Cognition Inc.
|
-9.7 Million USD
|
81.286%
|
HST Global, Inc.
|
-140.9 Thousand USD
|
-1189.02%
|
CSL Limited
|
3.7 Billion USD
|
100.049%
|
Wesana Health Holdings Inc.
|
-1.12 Million USD
|
-61.464%
|
Halberd Corporation
|
-75.05 Thousand USD
|
-2320.147%
|
Enzolytics Inc.
|
-2.14 Million USD
|
15.473%
|
Agentix Corp.
|
-1.37 Million USD
|
-32.408%
|
Resverlogix Corp.
|
-12.74 Million USD
|
85.753%
|
Nuo Therapeutics, Inc.
|
-3.16 Million USD
|
42.672%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-425.04 Million USD
|
99.573%
|
Enzon Pharmaceuticals, Inc.
|
-1.04 Million USD
|
-73.977%
|
Endonovo Therapeutics, Inc.
|
-2.91 Million USD
|
37.785%
|
RespireRx Pharmaceuticals Inc.
|
-1.57 Million USD
|
-15.004%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-3.4 Million USD
|
46.657%
|
AVAX Technologies, Inc.
|
6.69 Million USD
|
127.138%
|
Zenith Capital Corp.
|
-8.94 Million USD
|
79.69%
|
Genscript Biotech Corporation
|
-415.79 Million USD
|
99.563%
|
Ember Therapeutics, Inc.
|
-17.42 Thousand USD
|
-10326.038%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-2.45 Million USD
|
26.025%
|
WPD Pharmaceuticals Inc.
|
-171.5 Thousand USD
|
-959.02%
|
Cotinga Pharmaceuticals Inc.
|
-2 Million USD
|
9.399%
|
Kadimastem Ltd
|
-3.04 Million USD
|
40.258%
|
Helix BioMedix, Inc.
|
-984.05 Thousand USD
|
-84.575%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-1.25 Million USD
|
-44.611%
|
BioStem Technologies, Inc.
|
-7.77 Million USD
|
76.651%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-181.48 Thousand USD
|
-900.81%
|
LadRx Corporation
|
-3.82 Million USD
|
52.497%
|
Cell Source, Inc.
|
-4.32 Million USD
|
58.008%
|
Regen BioPharma, Inc.
|
-686.95 Thousand USD
|
-164.404%
|
Regen BioPharma, Inc.
|
-686.95 Thousand USD
|
-164.404%
|
NovAccess Global Inc.
|
-2.46 Million USD
|
26.368%
|
Affymax, Inc.
|
-15.04 Million USD
|
87.928%
|
Itoco Inc.
|
-919.14 Thousand USD
|
-97.611%
|
Rasna Therapeutics, Inc.
|
-4.23 Million USD
|
57.146%
|
Pathfinder Cell Therapy, Inc.
|
-1.11 Million USD
|
-62.316%
|
Mobile Lads Corp.
|
-554.55 Thousand USD
|
-227.53%
|
CytoDyn Inc.
|
-18.05 Million USD
|
89.942%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-25.17 Thousand USD
|
-7116.21%
|
NanoSphere Health Sciences Inc.
|
-220.07 Thousand USD
|
-725.307%
|
Alseres Pharmaceuticals, Inc.
|
-564.72 Thousand USD
|
-221.63%
|
SYBLEU INC
|
-149.18 Thousand USD
|
-1117.536%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
International Stem Cell Corporation
|
-663 Thousand USD
|
-173.955%
|
Bioxytran, Inc.
|
-3.82 Million USD
|
52.454%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
-52.64 Thousand USD
|
-3350.456%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-20.34 Thousand USD
|
-8829.794%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-36.26 Million USD
|
94.992%
|
Adhera Therapeutics, Inc.
|
-1.61 Million USD
|
-12.257%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-735.83 Thousand USD
|
-146.838%
|
Innovation Pharmaceuticals Inc.
|
-3.11 Million USD
|
41.616%
|
Neutra Corp.
|
-229.48 Thousand USD
|
-691.473%
|
Windtree Therapeutics, Inc.
|
-17.53 Million USD
|
89.644%
|
PureTech Health plc
|
-146.19 Million USD
|
98.758%
|
Coeptis Therapeutics, Inc.
|
-21.49 Million USD
|
91.549%
|
IXICO plc
|
-1.43 Million USD
|
-26.397%
|
IntelGenx Technologies Corp.
|
-9.49 Million USD
|
80.863%
|
Gelesis Holdings, Inc.
|
-121.8 Million USD
|
98.509%
|
CSL Limited
|
3.81 Billion USD
|
100.048%
|
Cellectis S.A.
|
-108.85 Million USD
|
98.331%
|